NASDAQ:BOLD | Free Cash Flow | Boundless Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$14.97M$8,000.00-$14.98M
2025-12-31-$10.11M$424,000.00-$10.53M
2025-03-31-$14.53M$59,000.00-$14.59M
2024-12-31-$15.56M$466,000.00-$16.03M
2024-03-31-$15.78M$83,000.00-$15.86M
2023-12-31-$11.69M$268,000.00-$11.95M
2023-03-31-$12.09M$86,000.00-$12.18M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$46.66M$546,000.00-$47.21M
2024-12-31-$60.84M$2.54M-$63.38M
2023-12-31-$46.86M$633,000.00-$47.49M